Mesalamine Enema
Product Images NDC 45802-098

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 45802-098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Structural Formula (Image 01)
This text is not available.*
FDA Label Image

Image 1 (Image 02)

FDA Label Image

Image 2 (Image 03)

FDA Label Image

Patient Image 3a (Image 04)

FDA Label Image

Image 3 (Image 05)

FDA Label Image

Image 4 (Image 06)

FDA Label Image

Image 07

Image 07
This is a medication description for Mesalamine Rectal Suspension USP Enema in 49/60 mL unit-dose bottles. It should be shaken well before use and is intended for rectal use only. The medication is prescribed and should only be used as directed (RxOnly).*
FDA Label Image

Serialization-template.jpg (Serialization Template)

Serialization-template.jpg (Serialization Template)
This text provides a template for recording essential information related to a specific product. It includes fields for the product's serial number, lot number, and expiration date. These details are crucial for tracking and managing inventory effectively.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.